Apertura
Apertura Gene Therapy
New York City, United States · Founded 2021 · $67.0M raised
- Headquarters
- New York City, New York
- Employees
- 11–50
- Founded
- 2021
- Business Model
- B2B
- Website
- aperturagtx.com
- Total Funding
- $67.0M
- Last Round
- $67.0M Series AApr 2022
- Rounds
- 1
About
Biotechnology company developing next-generation gene therapy capsids to treat debilitating rare diseases, founded on technology from the Broad Institute and Harvard.
Summary
Apertura is a Biotech company based in New York City, United States, founded in 2021. It has raised $67.0M in total across 1 round, most recently a $67.0M Series A round in Apr 2022. Investors include Deerfield Management.
Tech & App Stack
3 technologies & apps tracked
Create a free account — 25 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 25 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Apr 2022
Investors
Similar Companies
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract development and manufacturing organization (CDMO) focused exclusively on sterile ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.